Oxford Nanopore Technologies (LSE:ONT) EBITDA Margin % : -72.09% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Oxford Nanopore Technologies's EBITDA for the six months ended in Dec. 2023 was £-60.3 Mil. Oxford Nanopore Technologies's Revenue for the six months ended in Dec. 2023 was £83.7 Mil. Therefore, Oxford Nanopore Technologies's EBITDA margin for the quarter that ended in Dec. 2023 was -72.09%.

Oxford Nanopore Technologies EBITDA Margin % Historical Data

The historical data trend for Oxford Nanopore Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies EBITDA Margin % Chart

Oxford Nanopore Technologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

-124.90

-48.37

-105.05

-25.13

-62.44

Oxford Nanopore Technologies Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial					-145.21	-8.84	-51.27	-53.05	-72.09

Competitive Comparison of Oxford Nanopore Technologies's EBITDA Margin %

For the Biotechnology subindustry, Oxford Nanopore Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Nanopore Technologies's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's EBITDA Margin % falls into.

Oxford Nanopore Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Oxford Nanopore Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-105.935	/	169.668
	=	-62.44 %

Oxford Nanopore Technologies's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-60.314	/	83.666
	=	-72.09 %

Oxford Nanopore Technologies (LSE:ONT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Oxford Nanopore Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Nanopore Technologies (LSE:ONT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

ONTTF:USA ONTl:UK 4R0:Germany

Address

Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ

Website

https://www.nanoporetech.com

Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines